FATE
Fate Therapeutics Inc.
$1.15
+$0.04(+3.60%)
44
Overall
60
Value
36
Tech
36
Quality
Market Cap
$137.24M
Volume
1.41M
52W Range
$0.66 - $2.93
Target Price
$4.94
EPS Estimates Overview
| Current Quarter | $-0.27 | Next Quarter | $-0.3 |
| Current Year | $-1.15 | Next Year | $-1.16 |
| QoQ Growth | -11.1% | YoY Growth | -0.9% |
| 3Y EPS CAGR | +9.9% | Target Price | $4.94 |
| Consensus | Buy | Upside | +329.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | FATE | $1.15 | +3.6% | 1.41M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |